Document is current

Article History

Received: 30 November 2020

Accepted: 16 March 2021

First Online: 14 April 2021

Declarations

:

: Not applicable.

: Not applicable.

: All authors have completed the Unified Competing Interest form (available on request from the corresponding author). YC has received research grants and speaker’s honoraria from Baxter Healthcare, Fresenius medical care and Amgen. She is a current recipient of the NHMRC Early Career Fellowship. AVi is a current recipient of a Jacquot Research Establishment Fellowship. DJ has received consultancy fees, research grants, speaker’s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care; consultancy fees from Astra Zeneca and AWAK; speaker’s honoraria and travel sponsorships from ONO; and travel sponsorships from Amgen. He is a current recipient of an Australian National Health and Medical Research Council Practitioner Fellowship. CH has received grants from National Health and Medical Research Council, Shire and Baxter, and consultancy fees from GlaxoSmithKline and Astra Zeneca paid to her institution and outside the submitted work. MF has received research grants from Baxter Healthcare, Siemens Healthcare and Roche Diagnostics. NB has received an educational grant, advisory board consulting fees and honoraria from Baxter; advisory board consulting fees from Astra Zeneca; an educational grant and travel grant from Roche Pharmaceuticals; and a travel grant and educational grant from Amgen. RK has received consultancy fees, research grants, travel and speaker’s honoraria from Baxter Healthcare, travel sponsorships from Amgen and speaker’s honoraria from Shire. She is a current recipient of Queensland Advancing Clinical Research Fellowship. Staff members of AKTN are supported by NHMRC funding. The remaining authors have no competing interests to declare.